DexCom ( DXCM), a provider of continuous glucose monitoring systems, recently announced that the U.S. Food and Drug Administration (FDA) has cleared its new continuous glucose monitoring system, the ...
The black cellphone-sized device buzzed intently three times. 80 mg/dL, the screen urgently warned in bright red letters on a black background, LOW. Time to take a sip of Gatorade. The insistent ...
FDA classifies this as a Class I recall, which means using the device could result in adverse health effects or death. Dexcom Inc., has recalled its G4 Platinum and G5 Mobile continuous glucose ...
The Julphar revolutionary real-time continuous glucose monitoring device (CGM), DEXCOM G4 PLATINUM is now available in UAE, KSA, Kuwait and Oman and will soon be available in Qatar, Bahrain and ...
New Device for Diabetes Management is Most-Advanced CGM Available with up to 30% Improvement in Hypoglycemic Accuracy SAN DIEGO--(BUSINESS WIRE)-- Dexcom (NASDAQ: DXCM), a leader in continuous glucose ...
DexCom’s shares shot up as much as 8% in the trading session following the announcement. The stock has been up 2.6% since the news release. Currently, the DexCom G4 PLATINUM (Pediatric) is the only ...
DEXCOM G4 PLATINUM continuous glucose monitor by Dexcom Dexcom announced that the FDA has approved its Dexcom G4 Platinum continuous glucose monitor (CGM) for patients with diabetes. Dexcom announced ...
Dexcom has received approval from the FDA for a new version of its smartphone connected Dexcom Share platform that will eliminate the docking cradle and allow a patient's continuous glucose monitor ...
Tech Times announced our 2015 CES Best of Innovation Honorees and the list of winners included everything from Samsung's ultra-thin and powerful Series 9 2015 Edition Ultrabook to LG's 4K Ultra HD TV ...
The FDA has approved updat- ed, more accurate software for the Dexcom G4 Platinum pediatric continuous glucose monitoring (CGM) system. The approval, granted May 22, 2015, reflects soft-ware changes ...
SAN DIEGO--(BUSINESS WIRE)--DexCom, Inc., (NASDAQ:DXCM), a leader in continuous glucose monitoring (CGM) for patients with diabetes, announced today that it has received U.S. Food and Drug ...
Jonas, Who Has Type 1 Diabetes, Sings Praises for the Life-Changing Impact of Continuous Glucose Monitoring San Diego, CA, June 11, 2015 – Dexcom, Inc., (NASDAQ:DXCM), a leader in continuous glucose ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results